Company intelligence / Profile preview

Groundwork BioAg

Moshav Mazor, Central District, Israelgroundworkbioag.com ↗

Ownership: Private
Employees: ~34
Development stage: Commercial

Overview

Groundwork BioAg has developed and commercialized highly concentrated mycorrhizal inoculants that improve crop yields, enhance soil fertility, reduce fertilizer use, increase plant resilience to stress, and enable permanent carbon sequestration. Their Rootella products are used on millions of acres across more than 17 countries. The company also offers a "Rootella Carbon" program enabling farmers to generate revenue from verified carbon removal credits.

Modalities: Microbial therapyLive biotherapeutic product therapy
Industry: Agriculture & AgTech

Drug pipeline

1 asset

Rootella

Commercial

Indications: Agricultural soil enhancement

Partnerships

Sustainable Travel International (for offering carbon dioxide removal credits for tourism)

Beyond the preview

Go deeper on Groundwork BioAg.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Groundwork BioAg.

Explore the full profile